Hepatocellular Carcinoma (HCC) is a malignant tumor attacks hepatocytes. 5.4% of all malignancies in the world caused by HCC. Transarterial chemoembolization (TACE) has been shown to be effective in controlling tumor development and prolonging survival time. This study aims to determine the profile of HCC patients who were given TACE action at Ulin Hospital Banjarmasin for the 2016-2018 period. descriptive research method using medical record data. The results of the study obtained 29 HCC patients, 62% were aged >50 years; 65,5% gender male; 79,3% Child-Pugh B classification; 62% had liver cirrhosis as a predisposition; 65,5% abdominal pain was the most frequent complaint; 86.2% had radiological imaging; 79,3% ECOG performance value was 2, and 93.1% of patients had no thrombus in the portal vein. Conclusion: HCC patients who were given TACE therapy were the most at the age of >50 years and male gender, Child-Pugh B was the most, the most predisposition to liver disease was liver cirrhosis, the most frequent complaint the feeling is abdominal pain, most radiology imaging there is a typical imaging, the highest ECOG performance value is 2, and most patients do not have a thrombus in the portal vein or inferior vena cava. Keywords: Hepatocellular Carcinoma, TACE, liver cirrhosis Abstrak: Karsinoma Hepatoseluler (KHS) merupakan tumor ganas yang menyerang hepatosit. KHS menyebabkan 5,4% dari keganasan di dunia. Transarterial chemoembolization (TACE) efektif mengendalikan perkembangan tumor dan memperpanjang waktu hidup pada KHS. Penelitian bertujuan mengetahui profil pasien KHS yang mendapat TACE di RSUD Ulin Banjarmasin periode 2016-2018. Metode penelitian deskriptif, menggunakan data rekam medik. Hasil didapatkan 29 pasien KHS, 62% berumur >50 tahun; 65,5% laki-laki; 79,3% klasifikasi child-pugh B ; 62% memiliki sirosis hati sebagai predisposisi; 65,5% nyeri perut menjadi keluhan tersering; 86,2% memiliki gambaran khas radiologi; 79,3% nilai ECOG performance 2, dan 93,1% pasien tidak terdapat trombus pada vena porta. Kesimpulan: pasien KHS yang diberi terapi TACE adalah usia >50 tahun dan laki-laki paling banyak, klasifikasi child-pugh B terbanyak, predisposisi penyakit hati tersering sirosis hati, keluhan tersering nyeri perut, gambaran radiologi terbanyak terdapat gambaran khas, terbanyak nilai ECOG performance 2, dan kebanyakan pasien tidak terdapat trombus di vena porta/vena cava inferior. Kata Kunci: karsinoma hepatoseluler, TACE, sirosis hati
Abstract-Cadmium is expected to affect the absorption of other nutrients and appetite through the competition with the nutrients, causing damages to cell membranes through lipid peroxidation reactions. Damaged intestinal cells may disrupt the secretion of one of digestive hormones, ghrelin, theorexigenic hormone. The purpose of this study was to analyze the effect of cadmium exposure on the levels of ghrelin and malondialdehyde (MDA) in rats (Rattusnorvegicus). The study used post-test-only control group design, with 2 groups of white rats: control group (P0) was given placebo and treatment group (P1) was exposed to cadmium. Parameters measured were the levels of MDA and ghrelin. The results showed that there was no difference in body weights (p=0.057) and ghrelin concentrations (p=0.910) between the white rats in the control group and the treatment group. There were significant differences in the levels of MDA. The treatment group had a higher MDA level compared with control (p=0.001). It was concluded that the cadmium exposure for 4 group did not affect the secretion of ghrelin hormone and body weights of white rats, but might cause lipid peroxidation in white rats, as evidenced by the increased MDA level.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.